Jana Care

Janacare operates in the healthcare technology sector, focusing on innovative solutions for chronic disease management. The company develops paper-based test strips for biomarkers, which are crucial for screening and home monitoring of conditions like Type 2 Diabetes and Congestive Heart Failure. Janacare's core product, Aina, is a point-of-care screening platform that enables early detection and management of Type 2 Diabetes at a significantly reduced cost. Additionally, the company offers a digital coaching program called Habits, which uses biomarker data to deliver personalized care plans to patients. This program aims to improve patient outcomes by providing tailored health advice and monitoring.

Janacare primarily serves healthcare providers, patients, and health systems looking for cost-effective and efficient solutions for chronic disease management. The company operates in the global healthcare market, with a particular focus on regions with high prevalence of diabetes and heart failure. Janacare's business model revolves around the sale of its diagnostic devices and test strips, as well as subscription fees for its digital coaching services. Revenue is generated through direct sales to healthcare providers and partnerships with health systems.

Keywords: healthcare technology, chronic disease management, biomarker data, Type 2 Diabetes, Congestive Heart Failure, point-of-care screening, digital coaching, personalized care, cost-effective solutions, global healthcare market.